IT7920206A0 - Nuove ammidi derivate da acidi pirimidin-5-carbossilici, loro preparazione e loro applicazione in terapia. - Google Patents

Nuove ammidi derivate da acidi pirimidin-5-carbossilici, loro preparazione e loro applicazione in terapia.

Info

Publication number
IT7920206A0
IT7920206A0 IT7920206A IT2020679A IT7920206A0 IT 7920206 A0 IT7920206 A0 IT 7920206A0 IT 7920206 A IT7920206 A IT 7920206A IT 2020679 A IT2020679 A IT 2020679A IT 7920206 A0 IT7920206 A0 IT 7920206A0
Authority
IT
Italy
Prior art keywords
pyrimidin
therapy
preparation
application
carboxylic acids
Prior art date
Application number
IT7920206A
Other languages
English (en)
Other versions
IT1113438B (it
Inventor
Ancher Jean Francois
Bucher Bernard
Imbert Thierry
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7804921A external-priority patent/FR2417506A1/fr
Priority claimed from FR7902286A external-priority patent/FR2457286A2/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of IT7920206A0 publication Critical patent/IT7920206A0/it
Application granted granted Critical
Publication of IT1113438B publication Critical patent/IT1113438B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/38One sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT20206/79A 1978-02-21 1979-02-15 Nuove ammidi derivate da acidi pirimidin-5-carbossilici,loro preparazione e loro applicazione in terapia IT1113438B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7804921A FR2417506A1 (fr) 1978-02-21 1978-02-21 Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques utiles notamment dans le traitement des troubles du psychisme
FR7902286A FR2457286A2 (fr) 1979-01-30 1979-01-30 Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
IT7920206A0 true IT7920206A0 (it) 1979-02-15
IT1113438B IT1113438B (it) 1986-01-20

Family

ID=26220449

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20206/79A IT1113438B (it) 1978-02-21 1979-02-15 Nuove ammidi derivate da acidi pirimidin-5-carbossilici,loro preparazione e loro applicazione in terapia

Country Status (13)

Country Link
US (1) US4250178A (it)
JP (1) JPS54130585A (it)
AU (1) AU526298B2 (it)
CA (1) CA1096868A (it)
CH (1) CH639078A5 (it)
DE (1) DE2906461A1 (it)
ES (1) ES477852A1 (it)
GB (1) GB2014984B (it)
GR (1) GR66581B (it)
IT (1) IT1113438B (it)
LU (1) LU80937A1 (it)
NL (1) NL7901333A (it)
SE (1) SE446450B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133004B (en) * 1982-11-04 1986-06-11 Ici Plc Process for the extraction of metal values and novel metal extractants
US4743605A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase
DE4425143A1 (de) * 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
WO1997009315A1 (en) * 1995-09-01 1997-03-13 Signal Pharmaceuticals, Inc. Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
US5811428A (en) * 1995-12-18 1998-09-22 Signal Pharmaceuticals, Inc. Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
EP1034783B1 (en) * 1997-10-27 2004-12-15 Sumitomo Pharmaceuticals Company, Limited Amide derivatives for the treatment of retinal neurodegenerative disorders
US7504396B2 (en) * 2003-06-24 2009-03-17 Amgen Inc. Substituted heterocyclic compounds and methods of use
TW200827346A (en) 2006-11-03 2008-07-01 Astrazeneca Ab Chemical compounds
TW200836719A (en) * 2007-02-12 2008-09-16 Astrazeneca Ab Chemical compounds
WO2009098501A1 (en) * 2008-02-04 2009-08-13 Astrazeneca Ab Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid
CN102066335A (zh) * 2008-04-22 2011-05-18 阿斯利康(瑞典)有限公司 取代的嘧啶-5-甲酰胺281
AU2015315177A1 (en) * 2014-09-10 2017-03-16 Epizyme, Inc. Substituted pyrrolidine carboxamide compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789979A (en) * 1954-09-22 1957-04-23 Searle & Co Basically substituted nu-alkyl-2-amino-4-hydroxy-5-pyrimidine carboxamides and salts thereof

Also Published As

Publication number Publication date
DE2906461A1 (de) 1979-08-23
GB2014984B (en) 1982-06-09
GR66581B (it) 1981-03-27
IT1113438B (it) 1986-01-20
CA1096868A (en) 1981-03-03
SE7901493L (sv) 1979-08-22
US4250178A (en) 1981-02-10
ES477852A1 (es) 1979-08-01
SE446450B (sv) 1986-09-15
GB2014984A (en) 1979-09-05
CH639078A5 (fr) 1983-10-31
LU80937A1 (fr) 1979-10-29
AU4439279A (en) 1979-07-19
AU526298B2 (en) 1983-01-06
NL7901333A (nl) 1979-08-23
JPS54130585A (en) 1979-10-09

Similar Documents

Publication Publication Date Title
IT7923395A0 (it) N-aril-ossazolidinoni, -ossazolidintioni, -pirrolidinoni, -pirrolidine e -tiazolidinoni, loro procedimento di preparazione eloro applicazione in terapia.
DK197379A (da) 2,4-disubstituerede-5-thiazolcarboxylsyrer og derivater heraf
IT1094434B (it) Cinnamoil piperazione e cinnamoil omopiperazione,procedimento per la loro preparazione e loro applicazione in terapia
NL7806208A (nl) 7 alfa-methoxy-7 beta-(1,3-dithietan-2-carboxamide) ce- falosporanzuurderivaten en de bereiding, alsmede de toepassing ervan.
IT7948950A0 (it) Acidi lattamo-n-acetici e loro ammidi procedimento per prepararli e composizioni terapeutiche che licontengono
IT7920206A0 (it) Nuove ammidi derivate da acidi pirimidin-5-carbossilici, loro preparazione e loro applicazione in terapia.
IT1109095B (it) Acidi 1.3 ditietan 2 carbossilici e procedimento per la loro preparazione
IT1207271B (it) Amminoglicosidi, procedimento per la loro preparazione e loro impiego.
IT7830474A0 (it) 1-n-aril-1,4-di-idro-piridine e il loro impiego come prodotti medicinali.
IT1085949B (it) 2-benzil-pirrolidine,procedimento per la loro preparazione e prodotti medicinali che le contengono
FR2333504A1 (fr) Nouveaux derives de l'indazole, leur preparation et leur application comme medicaments
IT7925387A0 (it) 2-amminoetil-1-fenil-indoline, loro preparazione e loro applicazione come medicamenti.
NL7906624A (nl) 3,7-digesubstitueerde-3-cefem-4-carbonzuurverbindingen en hun bereiding.
IT1113449B (it) Derivati della n-fenil-alanina,loro prepatazione e loro impiego come prodotti medicinali
IT1115363B (it) Amminoalcossibenzofurani,loro procedimento di preparazione e loro applicazione in terapia
IT7827564A0 (it) 1,4-di-idro-piridazine, procedimento per la loro preparazione e loro impiego come prodotti medicinali.
IT7919650A0 (it) Prodotti microbicidi e procedimento per la loro preparazione.
IT7831447A0 (it) Acidi acil-idrocarbilammino-alcanoici, loro preparazione e loro impiego e anche prodotti medicinali che licontengono.
MA19290A1 (fr) Derives du benzole,leur preparaton et leur utilisations therapeutiques .
IT1059875B (it) Benzodiossani 1..4 loro procedimento di preparazione e loro applicazione in terapia
IT1075534B (it) Acidi 5-fenilcarbammoil-barbiturici,procedimento per la loro preparazione e loro impiego per combattere insetti
NL190120C (nl) 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen alsmede farmaceutisch preparaat daarvan.
BE867776R (fr) Derives d'acides thiazolidinecarboxyliques, leur preparation et leur application
BE863092R (fr) Derives de l'argininamide, leur preparation et leurs utilisations therapeutiques
BE856485A (fr) (2-azabicyclo(2.2.2)octane-2-yl) diphenylalcanones et derives et leur preparation et leurs utilisations therapeutiques